000187367 001__ 187367
000187367 005__ 20190316235644.0
000187367 0247_ $$2doi$$a10.5075/epfl-thesis-5838
000187367 02470 $$2urn$$aurn:nbn:ch:bel-epfl-thesis5838-6
000187367 02471 $$2nebis$$a9901097
000187367 037__ $$aTHESIS
000187367 041__ $$aeng
000187367 088__ $$a5838
000187367 245__ $$aNovel strategies for the development of anti-tuberculosis compounds
000187367 269__ $$a2013
000187367 260__ $$aLausanne$$bEPFL$$c2013
000187367 336__ $$aTheses
000187367 502__ $$aB. Lemaitre (président), J. Grosset, J. McKinney, P. Sander
000187367 6531_ $$atuberculosis
000187367 6531_ $$aMycobacterium tuberculosis
000187367 6531_ $$aSS18b
000187367 6531_ $$alatency
000187367 6531_ $$adrug discovery
000187367 6531_ $$aBTZ
000187367 6531_ $$aPBTZ
000187367 6531_ $$acombination therapy
000187367 6531_ $$avirulence
000187367 6531_ $$aESX-1
000187367 6531_ $$aEspI
000187367 700__ $$0244372$$aZhang, Ming$$g190482
000187367 720_2 $$0243892$$aCole, Stewart$$edir.$$g177247
000187367 8564_ $$s15696058$$uhttps://infoscience.epfl.ch/record/187367/files/EPFL_TH5838.pdf$$yn/a$$zn/a
000187367 909C0 $$0252302$$pUPCOL$$xU11742
000187367 909CO $$ooai:infoscience.tind.io:187367$$pSV$$pDOI$$pthesis$$qDOI2$$qGLOBAL_SET
000187367 917Z8 $$x108898
000187367 917Z8 $$x108898
000187367 918__ $$aSV$$cGHI$$dEDMS
000187367 919__ $$aUPCOL
000187367 920__ $$a2013-7-12$$b2013
000187367 970__ $$a5838/THESES
000187367 973__ $$aEPFL$$sPUBLISHED
000187367 980__ $$aTHESIS